Latest News
From the Journals
Women express low decision regret after preimplantation testing for aneuploidy
Most patients do not regret their decision to undergo preimplantation genetic testing for aneuploidy, but some experience low levels of regret.
From the Journals
Microvascular disease: An independent and exacerbating risk factor for amputation
The presence of microvascular disease plus peripheral artery disease resulted in a more than 20-fold increased risk of amputation than MVD or PAD...
From the Journals
Consider cutaneous endometriosis in women with umbilical lesions
Cutaneous endometriosis may occur because of seeding following abdominal or pelvic surgery.
From the Journals
Mortality caused by chronic liver disease in setting of diabetes continues to rise
The findings underscore the need to better address nonalcoholic fatty liver disease and end-stage liver disease among individuals with diabetes....
Conference Coverage
SGLT2 inhibitors for type 1 diabetes: Doctors debate the merits
SAN FRANCISCO – Cardiac and renal benefits and the need for more and better options, make these therapies appealing...
Feature
FDA warning letters fall on Trump’s watch
The FDA sent 33% fewer warning letters during the Trump administration’s first 28 months, compared with Obama’s final 28 months.
Conference Coverage
Some burnout factors are within a physician’s control
SAN DIEGO – Even in the face of daunting systemic factors, physicians can practice some important steps toward self-care.
Conference Coverage
VOC-sniffing necklace may support early detection of hypoglycemia
SAN FRANCISCO – Same trick as diabetes alert dogs – minus the pup.
From the Journals
Intervention tied to fewer depressive symptoms, more weight loss
“To our knowledge, this study was the first and largest RTC of integrated collaborative care for coexisting obesity and depression.”
Conference Coverage
New findings cast more doubt on ‘fat-but-fit’ theory
Conference Coverage
CAROLINA findings reaffirm linagliptin’s safety, free glimepiride of CV-risk stigma
SAN FRANCISCO – Concerns remain around glimepiride-related weight gain and hypoglycemia.